Omnicell, Inc. (OMCL) Q4 2025 Earnings Call Transcript

Omnicell, Inc. (OMCL) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 6, 2026

Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results.

Business Wire • Feb 5, 2026

Omnicell (OMCL) Q4 Earnings Lag Estimates

Omnicell (OMCL) came out with quarterly earnings of $0.4 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.6 per share a year ago.

Zacks Investment Research • Feb 5, 2026

OMCL or HIMS: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical Info Systems sector have probably already heard of Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Jan 30, 2026

Earnings Preview: Omnicell (OMCL) Q4 Earnings Expected to Decline

Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Jan 29, 2026

3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes

Medical Info Systems rides AI and telehealth tailwinds, lifting DOCS, TXG and OMCL, but cyber risks and industry underperformance keep optimism in check.

Zacks Investment Research • Jan 21, 2026

Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026.

Business Wire • Jan 13, 2026

All You Need to Know About Omnicell (OMCL) Rating Upgrade to Buy

Omnicell (OMCL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research • Jan 13, 2026

OMCL vs. HIMS: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical Info Systems sector have probably already heard of Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Jan 13, 2026

Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs

6,106 shares were sold for a transaction value of $243,629 on Dec. 3, 2025. The sale represented 5.85% of direct holdings, reducing direct ownership to 98,282 shares (0.2122% of shares outstanding).

The Motley Fool • Jan 5, 2026